{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_16329"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_16329","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"The role of Nrf2 in the activation of primary CD4 T cells from mice and humans","abstract":"Nuclear factor erythroid 2-related factor 2 (Nrf2) is a cytoprotective transcription factor activated by cellular stressors such as reactive oxygen species, electrophilic xenobiotics, and other forms of oxidative stress that regulates the transcription of a number of antioxidant, detoxification, and cytoprotective genes. Commonly used Nrf2 activators include 1[2-Cyano-3,12-di oxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im) and the food additive tert-butylhydroquinone (tBHQ). Nrf2 was initially characterized as a cytoprotective transcription factor, and has since been shown to have additional effects, including a role in the immune system. Nrf2-null mice are more sensitive to a number of inflammatory stimuli, and cell-type specific effects of Nrf2 have been observed, mainly in macrophages and dendritic cells. However, the role of Nrf2 in T cell function has not been well studied. Prior studies from our lab have shown that activation of Nrf2 skews murine CD4 T cell differentiation towards a Th2 (allergy-like) phenotype. However, the role of Nrf2 in T cell activation, which sets up T cells for differentiation, and in human T cells is unknown. The purpose of the present studies is to determine the role of Nrf2 in primary CD4 T cell activation to fill this gap. To do this, the Nrf2 activators tBHQ and CDDO-Im were used to determine effects on T cell activation in murine or human primary CD4 T cells. In mice, tBHQ inhibited production of the cytokines interleukin-2 (IL-2), interferon gamma (IFNγ), and granulocyte-macrophage colony stimulating factor (GM-CSF) in both wild-type and Nrf2-null splenocytes, and inhibited tumor necrosis factor alpha (TNFα) only in wild-type splenocytes. CDDO-Im inhibited IFNγ and TNFα production, and increased IL-2 production, in a largely Nrf2-dependent manner, and increased GM-CSF independently of Nrf2. Both tBHQ and CDDO-Im had little effect on expression of the cell surface proteins CD25 and CD69. Both tBHQ and CDDO-Im increased nuclear translocation of the transcription factor c-Jun in wild-type but not Nrf2-null splenocytes, and inhibited p65 NF-κB DNA binding in wild-type splenocytes. Overall, the data suggest that Nrf2 activation has differential effects on murine T cell activation. Nrf2 activation inhibits IFNγ and TNFα secretion and p65 NF-κB DNA binding, and increases production of IL-2 and translocation of c-Jun, with little effect on CD25 and CD69 expression. In primary human CD4 T cells, tBHQ inhibits events of T cell activation, including production of IL-2 and IFNγ, expression of CD25 and CD69, and p65 NF-κB DNA binding. CDDO-Im also inhibits IL-2 and IFNγ production, and CD25 and CD69 expression in primary human CD4 T cells. However, the role of Nrf2 in mediating these effects was undetermined, so a primary human CD4 T cell Nrf2 knockdown model was developed. Nucleofection with siRNA directed against Nrf2 knocked down Nrf2 protein expression by ~90% 12 h after transfection. Suppression of IL-2, IFNγ, TNFα, and GM-CSF production by tBHQ occurred in both the scrambled control and Nrf2-deficient CD4 T cells, as did inhibition of CD25 and CD69 expression. RNA-seq analysis was performed and identified a number of differentially expressed genes between the scrambled control and Nrf2-deficient CD4 T cells, as well as genes differentially expressed with tBHQ treatment, indicating potential areas in which Nrf2 may play a role in primary human CD4 T cell activation.","abstract_html":"Nuclear factor erythroid 2-related factor 2 (Nrf2) is a cytoprotective transcription factor activated by cellular stressors such as reactive oxygen species, electrophilic xenobiotics, and other forms of oxidative stress that regulates the transcription of a number of antioxidant, detoxification, and cytoprotective genes. Commonly used Nrf2 activators include 1[2-Cyano-3,12-di oxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im) and the food additive tert-butylhydroquinone (tBHQ). Nrf2 was initially characterized as a cytoprotective transcription factor, and has since been shown to have additional effects, including a role in the immune system. Nrf2-null mice are more sensitive to a number of inflammatory stimuli, and cell-type specific effects of Nrf2 have been observed, mainly in macrophages and dendritic cells. However, the role of Nrf2 in T cell function has not been well studied. Prior studies from our lab have shown that activation of Nrf2 skews murine CD4 T cell differentiation towards a Th2 (allergy-like) phenotype. However, the role of Nrf2 in T cell activation, which sets up T cells for differentiation, and in human T cells is unknown. The purpose of the present studies is to determine the role of Nrf2 in primary CD4 T cell activation to fill this gap. To do this, the Nrf2 activators tBHQ and CDDO-Im were used to determine effects on T cell activation in murine or human primary CD4 T cells. In mice, tBHQ inhibited production of the cytokines interleukin-2 (IL-2), interferon gamma (IFNγ), and granulocyte-macrophage colony stimulating factor (GM-CSF) in both wild-type and Nrf2-null splenocytes, and inhibited tumor necrosis factor alpha (TNFα) only in wild-type splenocytes. CDDO-Im inhibited IFNγ and TNFα production, and increased IL-2 production, in a largely Nrf2-dependent manner, and increased GM-CSF independently of Nrf2. Both tBHQ and CDDO-Im had little effect on expression of the cell surface proteins CD25 and CD69. Both tBHQ and CDDO-Im increased nuclear translocation of the transcription factor c-Jun in wild-type but not Nrf2-null splenocytes, and inhibited p65 NF-κB DNA binding in wild-type splenocytes. Overall, the data suggest that Nrf2 activation has differential effects on murine T cell activation. Nrf2 activation inhibits IFNγ and TNFα secretion and p65 NF-κB DNA binding, and increases production of IL-2 and translocation of c-Jun, with little effect on CD25 and CD69 expression. In primary human CD4 T cells, tBHQ inhibits events of T cell activation, including production of IL-2 and IFNγ, expression of CD25 and CD69, and p65 NF-κB DNA binding. CDDO-Im also inhibits IL-2 and IFNγ production, and CD25 and CD69 expression in primary human CD4 T cells. However, the role of Nrf2 in mediating these effects was undetermined, so a primary human CD4 T cell Nrf2 knockdown model was developed. Nucleofection with siRNA directed against Nrf2 knocked down Nrf2 protein expression by ~90% 12 h after transfection. Suppression of IL-2, IFNγ, TNFα, and GM-CSF production by tBHQ occurred in both the scrambled control and Nrf2-deficient CD4 T cells, as did inhibition of CD25 and CD69 expression. RNA-seq analysis was performed and identified a number of differentially expressed genes between the scrambled control and Nrf2-deficient CD4 T cells, as well as genes differentially expressed with tBHQ treatment, indicating potential areas in which Nrf2 may play a role in primary human CD4 T cell activation.","abstract_has_math":false,"creators":["Turley, Alexandra Elizabeth"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Rockwell, Cheryl E.","Ganey, Patricia","Hegg, Colleen","Lyuendyk, James P.","Michigan State University"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018","date_published":"2018","updated_at":"2026-11-18T17:41:28Z","subjects":["Transcription factors","T cells","Cellular control mechanisms","Genetic transcription--Regulation","Human immunogenetics","Veterinary immunogenetics"],"languages":["English"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:16329","isbn:9780355862133","isbn:0355862131","oclc:1047957135","umi:10791406","local:Turley_grad.msu_0128D_15925"],"render_values":[{"text":"etd:16329","href":null,"code":true},{"text":"isbn:9780355862133","href":null,"code":true},{"text":"isbn:0355862131","href":null,"code":true},{"text":"oclc:1047957135","href":null,"code":true},{"text":"umi:10791406","href":null,"code":true},{"text":"local:Turley_grad.msu_0128D_15925","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/6cjh-8h33","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/6cjh-8h33","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_16329","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Rockwell, Cheryl E.","Ganey, Patricia","Hegg, Colleen","Lyuendyk, James P.","Michigan State University"]},{"key":"dc:creator","label":"Author","values":["Turley, Alexandra Elizabeth"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2018"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["Text","Theses"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Transcription factors","T cells","Cellular control mechanisms","Genetic transcription--Regulation","Human immunogenetics","Veterinary immunogenetics"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:16329","isbn:9780355862133","isbn:0355862131","oclc:1047957135","umi:10791406","local:Turley_grad.msu_0128D_15925","https://doi.org/doi:10.25335/6cjh-8h33"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Nuclear factor erythroid 2-related factor 2 (Nrf2) is a cytoprotective transcription factor activated by cellular stressors such as reactive oxygen species, electrophilic xenobiotics, and other forms of oxidative stress that regulates the transcription of a number of antioxidant, detoxification, and cytoprotective genes. Commonly used Nrf2 activators include 1[2-Cyano-3,12-di oxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im) and the food additive tert-butylhydroquinone (tBHQ). Nrf2 was initially characterized as a cytoprotective transcription factor, and has since been shown to have additional effects, including a role in the immune system. Nrf2-null mice are more sensitive to a number of inflammatory stimuli, and cell-type specific effects of Nrf2 have been observed, mainly in macrophages and dendritic cells. However, the role of Nrf2 in T cell function has not been well studied. Prior studies from our lab have shown that activation of Nrf2 skews murine CD4 T cell differentiation towards a Th2 (allergy-like) phenotype. However, the role of Nrf2 in T cell activation, which sets up T cells for differentiation, and in human T cells is unknown. The purpose of the present studies is to determine the role of Nrf2 in primary CD4 T cell activation to fill this gap. To do this, the Nrf2 activators tBHQ and CDDO-Im were used to determine effects on T cell activation in murine or human primary CD4 T cells. In mice, tBHQ inhibited production of the cytokines interleukin-2 (IL-2), interferon gamma (IFNγ), and granulocyte-macrophage colony stimulating factor (GM-CSF) in both wild-type and Nrf2-null splenocytes, and inhibited tumor necrosis factor alpha (TNFα) only in wild-type splenocytes. CDDO-Im inhibited IFNγ and TNFα production, and increased IL-2 production, in a largely Nrf2-dependent manner, and increased GM-CSF independently of Nrf2. Both tBHQ and CDDO-Im had little effect on expression of the cell surface proteins CD25 and CD69. Both tBHQ and CDDO-Im increased nuclear translocation of the transcription factor c-Jun in wild-type but not Nrf2-null splenocytes, and inhibited p65 NF-κB DNA binding in wild-type splenocytes. Overall, the data suggest that Nrf2 activation has differential effects on murine T cell activation. Nrf2 activation inhibits IFNγ and TNFα secretion and p65 NF-κB DNA binding, and increases production of IL-2 and translocation of c-Jun, with little effect on CD25 and CD69 expression. In primary human CD4 T cells, tBHQ inhibits events of T cell activation, including production of IL-2 and IFNγ, expression of CD25 and CD69, and p65 NF-κB DNA binding. CDDO-Im also inhibits IL-2 and IFNγ production, and CD25 and CD69 expression in primary human CD4 T cells. However, the role of Nrf2 in mediating these effects was undetermined, so a primary human CD4 T cell Nrf2 knockdown model was developed. Nucleofection with siRNA directed against Nrf2 knocked down Nrf2 protein expression by ~90% 12 h after transfection. Suppression of IL-2, IFNγ, TNFα, and GM-CSF production by tBHQ occurred in both the scrambled control and Nrf2-deficient CD4 T cells, as did inhibition of CD25 and CD69 expression. RNA-seq analysis was performed and identified a number of differentially expressed genes between the scrambled control and Nrf2-deficient CD4 T cells, as well as genes differentially expressed with tBHQ treatment, indicating potential areas in which Nrf2 may play a role in primary human CD4 T cell activation.","Thesis (Ph. D.)--Michigan State University. Pharmacology and Toxicology, Environmental Toxicology, 2018","Includes bibliographical references (pages 147-179)"]},{"key":"dc:format","label":"Dc Format","values":["xviii, 179 pages","application/pdf"]},{"key":"dc:title","label":"Title","values":["The role of Nrf2 in the activation of primary CD4 T cells from mice and humans"]}]}],"canonical_facts":{"dc:contributor":["Rockwell, Cheryl E.","Ganey, Patricia","Hegg, Colleen","Lyuendyk, James P.","Michigan State University"],"dc:creator":["Turley, Alexandra Elizabeth"],"dc:date":["2018"],"dc:description":["Nuclear factor erythroid 2-related factor 2 (Nrf2) is a cytoprotective transcription factor activated by cellular stressors such as reactive oxygen species, electrophilic xenobiotics, and other forms of oxidative stress that regulates the transcription of a number of antioxidant, detoxification, and cytoprotective genes. Commonly used Nrf2 activators include 1[2-Cyano-3,12-di oxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im) and the food additive tert-butylhydroquinone (tBHQ). Nrf2 was initially characterized as a cytoprotective transcription factor, and has since been shown to have additional effects, including a role in the immune system. Nrf2-null mice are more sensitive to a number of inflammatory stimuli, and cell-type specific effects of Nrf2 have been observed, mainly in macrophages and dendritic cells. However, the role of Nrf2 in T cell function has not been well studied. Prior studies from our lab have shown that activation of Nrf2 skews murine CD4 T cell differentiation towards a Th2 (allergy-like) phenotype. However, the role of Nrf2 in T cell activation, which sets up T cells for differentiation, and in human T cells is unknown. The purpose of the present studies is to determine the role of Nrf2 in primary CD4 T cell activation to fill this gap. To do this, the Nrf2 activators tBHQ and CDDO-Im were used to determine effects on T cell activation in murine or human primary CD4 T cells. In mice, tBHQ inhibited production of the cytokines interleukin-2 (IL-2), interferon gamma (IFNγ), and granulocyte-macrophage colony stimulating factor (GM-CSF) in both wild-type and Nrf2-null splenocytes, and inhibited tumor necrosis factor alpha (TNFα) only in wild-type splenocytes. CDDO-Im inhibited IFNγ and TNFα production, and increased IL-2 production, in a largely Nrf2-dependent manner, and increased GM-CSF independently of Nrf2. Both tBHQ and CDDO-Im had little effect on expression of the cell surface proteins CD25 and CD69. Both tBHQ and CDDO-Im increased nuclear translocation of the transcription factor c-Jun in wild-type but not Nrf2-null splenocytes, and inhibited p65 NF-κB DNA binding in wild-type splenocytes. Overall, the data suggest that Nrf2 activation has differential effects on murine T cell activation. Nrf2 activation inhibits IFNγ and TNFα secretion and p65 NF-κB DNA binding, and increases production of IL-2 and translocation of c-Jun, with little effect on CD25 and CD69 expression. In primary human CD4 T cells, tBHQ inhibits events of T cell activation, including production of IL-2 and IFNγ, expression of CD25 and CD69, and p65 NF-κB DNA binding. CDDO-Im also inhibits IL-2 and IFNγ production, and CD25 and CD69 expression in primary human CD4 T cells. However, the role of Nrf2 in mediating these effects was undetermined, so a primary human CD4 T cell Nrf2 knockdown model was developed. Nucleofection with siRNA directed against Nrf2 knocked down Nrf2 protein expression by ~90% 12 h after transfection. Suppression of IL-2, IFNγ, TNFα, and GM-CSF production by tBHQ occurred in both the scrambled control and Nrf2-deficient CD4 T cells, as did inhibition of CD25 and CD69 expression. RNA-seq analysis was performed and identified a number of differentially expressed genes between the scrambled control and Nrf2-deficient CD4 T cells, as well as genes differentially expressed with tBHQ treatment, indicating potential areas in which Nrf2 may play a role in primary human CD4 T cell activation.","Thesis (Ph. D.)--Michigan State University. Pharmacology and Toxicology, Environmental Toxicology, 2018","Includes bibliographical references (pages 147-179)"],"dc:format":["xviii, 179 pages","application/pdf"],"dc:identifier":["etd:16329","isbn:9780355862133","isbn:0355862131","oclc:1047957135","umi:10791406","local:Turley_grad.msu_0128D_15925","https://doi.org/doi:10.25335/6cjh-8h33"],"dc:language":["English"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Transcription factors","T cells","Cellular control mechanisms","Genetic transcription--Regulation","Human immunogenetics","Veterinary immunogenetics"],"dc:title":["The role of Nrf2 in the activation of primary CD4 T cells from mice and humans"],"dc:type":["Text","Theses"]},"updated_at":"2026-11-18T17:41:28Z"}